These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37180636)

  • 1. Epidemiology of Nontuberculous Mycobacteria in Nanjing and
    Zhang R; Luo S; Wang N; Zhang H; Wu X
    Infect Drug Resist; 2023; 16():2751-2764. PubMed ID: 37180636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.
    Gutiérrez AV; Richard M; Roquet-Banères F; Viljoen A; Kremer L
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332077
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial Susceptibility Testing Using the MYCO Test System and MIC Distribution of 8 Drugs against Clinical Isolates of Nontuberculous Mycobacteria from Shanghai.
    Ying R; Yang J; Wu X; Yu F; Sha W
    Microbiol Spectr; 2023 Feb; 11(2):e0254922. PubMed ID: 36802218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in
    Richard M; Gutiérrez AV; Viljoen A; Rodriguez-Rincon D; Roquet-Baneres F; Blaise M; Everall I; Parkhill J; Floto RA; Kremer L
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus.
    Chen Y; Chen J; Zhang S; Shi W; Zhang W; Zhu M; Zhang Y
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712660
    [No Abstract]   [Full Text] [Related]  

  • 6. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
    J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bedaquiline, Delamanid, Linezolid, Clofazimine, and Capreomycin MIC Distributions for Drug Resistance
    Guo Y; Yang J; Wang W; Wu X; Wan B; Wang H; Sha W; Yu F
    Infect Drug Resist; 2023; 16():7587-7595. PubMed ID: 38107433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease.
    Kim DH; Kim BG; Kim SY; Huh HJ; Lee NY; Koh WJ; Kim H; Kwon OJ; Jhun BW
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients.
    Gao J; Pei Y; Yan X; Shi G; Li T; Gao M; Liu Y; Wang Y; Shu W; Li L; Pang Y
    Int J Infect Dis; 2020 Nov; 100():196-198. PubMed ID: 32890726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium,
    Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y
    Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhu R; Shang Y; Chen S; Xiao H; Ren R; Wang F; Xue Y; Li L; Li Y; Chu N; Huang H
    Microbiol Spectr; 2022 Dec; 10(6):e0137222. PubMed ID: 36250885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China.
    Zheng H; He W; Jiao W; Xia H; Sun L; Wang S; Xiao J; Ou X; Zhao Y; Shen A
    BMC Infect Dis; 2021 Apr; 21(1):330. PubMed ID: 33832459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study.
    Hajikhani B; Nasiri MJ; Hosseini SS; Khalili F; Karimi-Yazdi M; Hematian A; Nojookambari NY; Goudarzi M; Dadashi M; Mirsaeidi M
    J Glob Antimicrob Resist; 2021 Sep; 26():188-193. PubMed ID: 34153525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.